Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Press Release Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern,

FirstWordPharmaDecember 06, 2021

Tag: SARS-CoV-2 MPro inhibitors , MPI8 , cathepsin

PharmaSources Customer Service